Dr. Reddy’s Q2 net dips 32% to ₹913 cr on lower revenue
Dr. Reddy’s Laboratories reported a 32% decline in net profit for the September quarter, falling to ₹913.2 crore from ₹1,336.8 crore last year. Revenue from operations decreased to ₹8,697.8 crore, down from ₹8,828.3 crore, primarily due to lower sales in the North American market. The company aims to address these challenges in upcoming quarters.